SummitTX Capital »

Enanta Pharmaceuticals shares owned by SummitTX Capital

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 258k 14.58

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Analog Devices (ADI)
MKS Instruments (MKSI)
Asml Hldg Nv N Y Registry Shs (ASML)
Warner Bros Discovery Com Ser A (WBD)
Applied Materials (AMAT)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Nxp Semiconductors N V (NXPI)
Amazon (AMZN)
O'reilly Automotive (ORLY)
Cbre Group Cl A (CBRE)
Electronic Arts (EA)
Micron Technology (MU)
3M Company (MMM)

View all positions for SummitTX Capital

Top funds holding Enanta Pharmaceuticals

Henderson Group
Jupiter Topco
BlackRock
Krensavage Asset Management
Farallon Capital Management
Deep Track Capital
ADAR1 Capital Management
Vanguard Capital Management
Spruce Street Capital
Acadian Asset Management
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
State Street Corporation
Renaissance Technologies

View all funds holding Enanta Pharmaceuticals